Mark Löwenberg
Department of Gastroenterology and Hepatology
Academic Medical Center
Meibergdreef 9
1105 AZ Amsterdam
Netherlands
Name/email consistency: high
- Mucosal healing in Crohn's disease: relevance for clinical outcomes. Lowenberg, M., D'Haens, G. Curr. Drug. Targets (2012)
- Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Löwenberg, M., Stahn, C., Hommes, D.W., Buttgereit, F. Steroids (2008)
- Proximal signaling molecules as potential targets for anti-inflammatory therapy. Löwenberg, M. Curr. Opin. Drug. Discov. Devel (2007)
- Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Löwenberg, M., Verhaar, A.P., van den Brink, G.R., Hommes, D.W. Trends. Mol. Med (2007)
- Kinome analysis reveals nongenomic glucocorticoid receptor-dependent inhibition of insulin signaling. Löwenberg, M., Tuynman, J., Scheffer, M., Verhaar, A., Vermeulen, L., van Deventer, S., Hommes, D., Peppelenbosch, M. Endocrinology (2006)
- Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. Löwenberg, M., Verhaar, A.P., Bilderbeek, J., Marle, J., Buttgereit, F., Peppelenbosch, M.P., van Deventer, S.J., Hommes, D.W. EMBO Rep. (2006)
- Biological therapy in the management of recent-onset Crohn's disease: why, when and how?. Löwenberg, M., Peppelenbosch, M., Hommes, D. Drugs (2006)
- Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Löwenberg, M., Tuynman, J., Bilderbeek, J., Gaber, T., Buttgereit, F., van Deventer, S., Peppelenbosch, M., Hommes, D. Blood (2005)
- Specific inhibition of c-Raf activity by semapimod induces clinical remission in severe Crohn's disease. Löwenberg, M., Verhaar, A., van den Blink, B., ten Kate, F., van Deventer, S., Peppelenbosch, M., Hommes, D. J. Immunol. (2005)
- Therapeutic modulation of signal transduction pathways. Löwenberg, M., Peppelenbosch, M.P., Hommes, D.W. Inflamm. Bowel Dis. (2004)
